Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Mar 1, 2024
- Accession no.
- 0001022079-24-000083
- Filed
- Mar 1, 2024
- Trade date
- Feb 28-29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $706.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Common Stock | FTax withholdingDisposed | −405 | $126.36 | −$51,175.8 | 44,545 | Direct | |
| Feb 28, 2024 | Common Stock | FTax withholdingDisposed | −456 | $126.36 | −$57,620.16 | 44,089 | Direct | |
| Feb 29, 2024 | Common Stock | SSaleDisposed | −5,611 | $125.88 | −$706,312.68 | 38,478 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.